CN104258079A - Traditional Chinese medicine for treating chronic bronchitis - Google Patents
Traditional Chinese medicine for treating chronic bronchitis Download PDFInfo
- Publication number
- CN104258079A CN104258079A CN201410541754.8A CN201410541754A CN104258079A CN 104258079 A CN104258079 A CN 104258079A CN 201410541754 A CN201410541754 A CN 201410541754A CN 104258079 A CN104258079 A CN 104258079A
- Authority
- CN
- China
- Prior art keywords
- parts
- chronic bronchitis
- chinese medicine
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 23
- 206010006458 Bronchitis chronic Diseases 0.000 title claims abstract description 22
- 208000007451 chronic bronchitis Diseases 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 241001517368 Coelogyne Species 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241000490499 Cardamine Species 0.000 claims description 9
- 244000030166 artemisia Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 3
- 240000000377 Tussilago farfara Species 0.000 abstract description 2
- 235000004869 Tussilago farfara Nutrition 0.000 abstract description 2
- 240000008399 Barbarea vulgaris Species 0.000 abstract 1
- 235000008473 Cardamine hirsuta Nutrition 0.000 abstract 1
- 235000014412 Cardamine oligosperma Nutrition 0.000 abstract 1
- 241001369613 Stephania tetrandra Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 20
- 208000006673 asthma Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000037656 Respiratory Sounds Diseases 0.000 description 5
- 206010047924 Wheezing Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 description 4
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 235000008384 feverfew Nutrition 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010044302 Tracheitis Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 241001523383 Achnatherum Species 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241001229802 Aster souliei Species 0.000 description 1
- 241001427932 Bothragonus swanii Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000549615 Cardamine leucantha Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 241001149110 Limonium wrightii Species 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000258712 Runaria Species 0.000 description 1
- 241000132004 Symphyotrichum cordifolium Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating the chronic bronchitis. The traditional Chinese medicine is prepared from bulk drugs in parts by weight as follows: 12 parts of whiteflowered bittercress roots, 16 parts of seremban, 7 parts of nepal pearleverlasting herb, 11 parts of fourstamen stephania roots, 6 parts of flos asteris souliei, 5 parts of common coltsfoot flowers and 23 parts of corymbose coelogyne pseudobulb. Clinical experiments prove that the traditional Chinese medicine can be used for treating the chronic bronchitis safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine being used for the treatment of chronic bronchitis.
Background technology
Chronic bronchitis is owing to infect or non-infective agent causes the chronic nonspecific inflammation of trachea-bronchial epithelial cell mucosa and surrounding tissue thereof.Its pathological characteristic is bronchus glandular hyperplasia, mucilage secretion increases.Clinically have continuous more than 2 years, the symptoms such as the cough often continuing more than three months, expectoration or asthma.Early symptom is slight, how to show effect in the winter time, alleviates after the spring is warm; Late phase inflammation increases the weight of, and symptom exists all the year round, regardless of season.Progression of disease again can concurrent obstructive emphysema, pulmonary heart disease, has a strong impact on labour force and health.Chronic bronchitis belongs to the category such as the traditional Chinese medical science " cough ", " the syndrome of dyspnea ", " phlegm retention ".Ancient Chinese medicine doctor all has more detailed record." Plain Questions " special train " coughing an opinion " section, proposes " vital organs of the human body all make us coughing, and non-only lung also ".Bright Zhang Jingyue proposes cough not from diseases caused by exogenous pathogenic factor, the saying of internal injury.Diseases caused by exogenous pathogenic factor are that six climate exopathogens violate lung, and internal injury is visceral dysfunction, send out as cough with asthma is for performance eventually with impairment of dispersing and descending function of the lung, abnormal rising of lung-QI.Weakened body resistance according to the domination of pathogen in treatment, control with eliminating evil cough-relieving, righting tonify deficiency.
Medical material present Research involved in the present invention is as follows:
Radix cardamines leucanthae [another name] Caulis et Folium Brassicae junceae, false Herba Apii graveolentis, Herba Incarvilleae sinensis, spend root stock or herb that stone Caulis et Folium Brassicae junceae [source] is crucifer Cardamine leucantha in vain.Autumn excavates, and removes earth impurity and fibrous root, dries.[habitats distribution] is distributed in the ground such as northeast, Shanxi, Shaanxi, Gansu, Jiangsu, Anhui, Zhejiang, Jiangxi, Henan, Hubei, Hunan, Sichuan.[nature and flavor] are pungent; Sweet; Flat [function cures mainly] preventing phlegm from forming and stopping coughing; Promoting blood circulation and stopping pain.Main pertussis; Chronic bronchitis; Have through uncomfortable; Traumatic injury.[usage and dosage] takes orally: decoct soup, 6-15g.[extracts] " China's book on Chinese herbal medicine "
Chinese mugwort [another name] Artemisia argyi Levl. et Van. var. argyi cv. Qiai in thousand, Coagulum Opuntiae sucus, Folium Crossostephii Chinensis, Bai Ai, white Folium Crossostephii Chinensis, beeweed, white Hibisci Mutabilis, Limonium wrightii Kuntz, rock head be [source] leaf that is feverfew Hibisci Mutabilis chrysanthemum in vain.The whole year all can adopt, and cleans, using fresh herb or dry.[nature and flavor] acrid in the mouth; Bitter; Slightly warm in nature.[function cures mainly] dispersing wind and cold; Reduce phlegm dampness removing; Removing toxic substances and promoting subsidence of swelling.Main anemofrigid cold; Cough with copious phlegm; Pertussis; Have loose bowels; Stranguria with turbid discharge; Leucorrhea; Carbuncle furunculosis.[usage and dosage] takes orally: decoct soup, 15-30g.External: appropriate, smashes deposited.[extracts] " China's book on Chinese herbal medicine "
Herba Anaphalidis Nepalensis [another name] fragrant blue or green [source] is the fragrant blue or green herb of feverfew Nepal.The 6-9 month gathers after spending, and cleans, dries.[nature and flavor] sweet in the mouth; Property is put down.[function cures mainly] heat clearing away suppressing the hyperactive liver; Relieving cough and relieving asthma.Main cold cough; Acute and chronic tracheitis; Prop up gas and asthma; Hypertension.[usage and dosage] takes orally: decoct soup, 3-12g.[extracts] " China's book on Chinese herbal medicine "
The root that large fruit bar halberd [another name] button lamp, Radix Stephaniae Tetrandrae, Vietnam's Herba Morindae Parvifoliae, Herba Paederiae Tomentosae [source] are the large fruit Radix Morindae Officinalis of Maguireothamnus speciosus.Autumn uproots, and cleans, dries.[nature and flavor] are pungent; Micro-hardship; Cool.[function cures mainly] expelling wind and removing dampness; Lung qi dispersing cough-relieving.Main air pain of dampness syndrome; Flu; Bronchitis; Upper respiratory tract infection.[usage and dosage] takes orally: decoct soup, 10-15g.[extracts] " China's book on Chinese herbal medicine "
Hide head inflorescence or root that Radix Asteris [another name] blue or green aster [source] this product is feverfew Aster souliei.5-7 to gather cephaloid the florescence month, dries in the shade; Spring, autumn uproot, and removing stem and leaf, cleans, dry.[nature and flavor] bitter in the mouth; Cold in nature.[function cures mainly] heat-clearing and toxic substances removing; Relieving cough and resolving phlegm.Main influenza; Tracheitis.[usage and dosage] takes orally: decoct soup, 3-9g; Or enter ball, loose.[extracts] " China's book on Chinese herbal medicine "
Flos Farfarae [another name] Flos Farfarae, money flower, see snuff, Ai Donghua, 99 flowers [sources] alabastrum that is feverfew coltsfoot.[nature and flavor] acrid in the mouth; Micro-sweet; Warm in nature.[return through] returns lung meridian.[function cures mainly] nourishing the lung to keep the adverse QI downward; Preventing phlegm from forming and stopping coughing.Main new chronic cough is coughed; Asthma; Chronic cough hemoptysis.[usage and dosage] takes orally: decoct soup, 3-10g; Or endure cream; Or enter ball, loose.External: appropriate, grinds into powder and dresses.[extracts] " China's book on Chinese herbal medicine "
Pseudobulbus Coelogynes corymbosae [another name] Shi Bajiao, be pseudobulb or the herb of orchid umbrella room Pseudobulbus Coelogynes corymbosae to leaf fruit, Herba Bulbophylli Odoratissim, hemostasis fruit, little green splendid achnatherum [source] this product.The whole year all can gather, and cleans, dries or using fresh herb after steaming.[nature and flavor] are pungent; Sweet; Cool.[return through] lung; Kidney channel.[function cures mainly] clearing and antitussive; Hemostasis analgesic therapy.Main bronchus is scorching; Flu; Fracture; Soft tissue contusion; Traumatic hemorrhage.[usage and dosage] takes orally: decoct soup, 15-30g.External: appropriate, fresh goods is smash deposited; Or dry product is ground into powder and is dressed.[extracts] " China's book on Chinese herbal medicine "
Summary of the invention
The present invention aims to provide a kind of Chinese medicine being used for the treatment of chronic bronchitis, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing chronic bronchitis.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of Chinese medicine being used for the treatment of chronic bronchitis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix cardamines leucanthae 12 parts, Chinese mugwort in thousand 16 parts, Herba Anaphalidis Nepalensis 7 parts, large fruit bar halberd 11 parts, hide Radix Asteris 6 parts, Flos Farfarae 5 parts, Pseudobulbus Coelogynes corymbosae 23 parts.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor in JIUYUE, 2011 ~ 2013 collect chronic bronchitis patient 70 example of outpatient clinic altogether between year April, all meet chronic bronchitis diagnostic criteria.Treatment group 35 example, matched group 35 example.Two groups of cases in sex, age, the course of disease and the state of an illness relatively in table 1.
A table 1 liang group patient basic condition compares
Two groups of patients compare P and are all greater than 0.05 in sex, age, the course of disease and the state of an illness as seen from the above table, have comparability.
2, test method
2.1 Therapeutic Method
The decoct that the oral the present invention for the treatment of group obtains according to specific embodiment 1, every day 3 times.4 weeks courses for the treatment of.
The oral levofloxacin of matched group (using according to its description), 4 weeks courses for the treatment of.
Clinical observation is coughed, pant, physical signs of lung and breathe hard, weak, xerostomia, sweating and the change of tongue arteries and veins.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
With reference to " guideline of clinical investigations of new Chinese medicine treatment chronic bronchitis " of Ministry of Public Health formulation in 1999.
Recovery from illness: cough, expectorant, asthma shape disappear substantially, pulmonary's wheezing sound is slight person, observation index is improved to normal or is significantly improved;
Effective: cough, expectorant, asthma shape be clearly better, pulmonary's wheezing sound obviously alleviates, and observation index obviously improves;
Effective: cough, expectorant, asthma shape take a turn for the better, pulmonary's wheezing sound alleviates, observation index part improve;
Invalid: to cough, expectorant, asthma shape and pulmonary's wheezing sound without change, or alleviate not obvious, and symptom and wheezing sound add severe one, observation index is without improvement.
Effectively total=recovery from illness+effective+effectively.
3.2 therapeutic outcome
The comprehensive therapeutic effect of two groups compares in table 2.
A table 2 liang group comprehensive therapeutic effect compares
It is high and not easily recur that visible the present invention is used for the treatment of chronic bronchitis cure rate, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take: Radix cardamines leucanthae 12 grams, Chinese mugwort in thousand 16 grams, Herba Anaphalidis Nepalensis 7 grams, large fruit bar halberd 11 grams, hide Radix Asteris 6 grams, Flos Farfarae 5 grams, Pseudobulbus Coelogynes corymbosae 23 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of chronic bronchitis.Oral, every bu morning, noon and afternoon take for three times.
Specific embodiment 2
Take: Radix cardamines leucanthae 12 grams, Chinese mugwort in thousand 16 grams, Herba Anaphalidis Nepalensis 7 grams, large fruit bar halberd 11 grams, hide Radix Asteris 6 grams, Flos Farfarae 5 grams, Pseudobulbus Coelogynes corymbosae 23 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of chronic bronchitis.Oral, every bu morning, noon and afternoon take for three times.
Specific embodiment 3
Take: Radix cardamines leucanthae 12 grams, Chinese mugwort in thousand 16 grams, Herba Anaphalidis Nepalensis 7 grams, large fruit bar halberd 11 grams, hide Radix Asteris 6 grams, Flos Farfarae 5 grams, Pseudobulbus Coelogynes corymbosae 23 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of chronic bronchitis.Oral, every bu morning, noon and afternoon take for three times.
Claims (4)
1. one kind is used for the treatment of the Chinese medicine of chronic bronchitis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix cardamines leucanthae 12 parts, Chinese mugwort in thousand 16 parts, Herba Anaphalidis Nepalensis 7 parts, large fruit bar halberd 11 parts, hide Radix Asteris 6 parts, Flos Farfarae 5 parts, Pseudobulbus Coelogynes corymbosae 23 parts.
2. a kind of Chinese medicine being used for the treatment of chronic bronchitis as claimed in claim 1, it is characterized in that, its preparation method is: Radix cardamines leucanthae 12 parts, Chinese mugwort in thousand 16 parts, Herba Anaphalidis Nepalensis 7 parts, large fruit bar halberd 11 parts, hide Radix Asteris 6 parts, Flos Farfarae 5 parts, Pseudobulbus Coelogynes corymbosae 23 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. a kind of Chinese medicine being used for the treatment of chronic bronchitis as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix cardamines leucanthae 12 parts, Chinese mugwort in thousand 16 parts, Herba Anaphalidis Nepalensis 7 parts, large fruit bar halberd 11 parts, hide Radix Asteris 6 parts, Flos Farfarae 5 parts, Pseudobulbus Coelogynes corymbosae 23 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. a kind of Chinese medicine being used for the treatment of chronic bronchitis as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix cardamines leucanthae 12 parts, Chinese mugwort in thousand 16 parts, Herba Anaphalidis Nepalensis 7 parts, large fruit bar halberd 11 parts, hide Radix Asteris 6 parts, Flos Farfarae 5 parts, Pseudobulbus Coelogynes corymbosae 23 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410541754.8A CN104258079A (en) | 2014-10-12 | 2014-10-12 | Traditional Chinese medicine for treating chronic bronchitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410541754.8A CN104258079A (en) | 2014-10-12 | 2014-10-12 | Traditional Chinese medicine for treating chronic bronchitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104258079A true CN104258079A (en) | 2015-01-07 |
Family
ID=52149736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410541754.8A Pending CN104258079A (en) | 2014-10-12 | 2014-10-12 | Traditional Chinese medicine for treating chronic bronchitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104258079A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105708955A (en) * | 2016-04-13 | 2016-06-29 | 刘海强 | Medicine for treating chronic bronchitis |
-
2014
- 2014-10-12 CN CN201410541754.8A patent/CN104258079A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 张思云等: "《食疗健身妙方》", 30 November 2013, 贵州科技出版社 * |
| 杨毅勇: "慢性支气管炎中医辨证论治", 《同济大学学报(医学版)》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105708955A (en) * | 2016-04-13 | 2016-06-29 | 刘海强 | Medicine for treating chronic bronchitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101628108B (en) | Traditional Chinese medicinal granules for treating wind-cold evil and preparation method thereof | |
| CN103263531B (en) | Chinese medicine composition for treating prosopalgia and preparation method thereof | |
| CN105748900A (en) | Traditional Chinese medicine for treating chronic laryngitis and preparation method of traditional Chinese medicine | |
| CN104225399A (en) | Traditional Chinese medicine for treating pulmonary tuberculosis | |
| CN105497723A (en) | Traditional Chinese medicine preparation for treating bacterial pneumonia and preparation method thereof | |
| CN104784328A (en) | Traditional Chinese medicine for treating chronic sinusitis | |
| CN102145070B (en) | Traditional Chinese medicine for treating rheumatic heart disease | |
| CN104258079A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN111973705A (en) | Traditional Chinese medicine composition for treating interstitial lung disease, pharmaceutical preparation and application | |
| CN105343274A (en) | Drug combination having inflammation diminishing and cough relieving functions | |
| CN106974970B (en) | Medicine for treating thyroid nodule and preparation method and use method thereof | |
| CN103285193A (en) | Lung-tonifying capsule for treating lung-distension caused by qi deficiency of lung and kidney and preparation method thereof | |
| CN112641871B (en) | Pharmaceutical composition for treating phlegm-heat accumulated in lung | |
| CN105709152A (en) | Traditional Chinese medicine preparation for treating pulmonary heart disease and preparation method thereof | |
| CN105943871A (en) | Traditional Chinese medicine preparation for treating lung abscess and preparation method thereof | |
| CN105853749A (en) | Pharmaceutical preparation for treating chronic pneumonia and preparing method | |
| CN102895322B (en) | Medicament composition for treating pulmonary interstitial fibrosis as well as preparation method and applications thereof | |
| CN105168788A (en) | Traditional Chinese medicinal preparation for treating chronic bronchitis | |
| CN105168763A (en) | Traditional Chinese medicine treating herpes simplex keratitis | |
| CN104906439A (en) | Medicine for treating chronic respiratory failure | |
| CN104623319A (en) | Traditional Chinese medicine for treating arrhythmia caused by timidity due to deficiency of heart qi and preparation method of traditional Chinese medicine | |
| CN104586974A (en) | Traditional Chinese medicine for treating lung-heat cough | |
| CN104055886A (en) | Medicinal composition for treating chronic cough, and preparation method and application thereof | |
| CN107485683A (en) | A kind of Chinese and Western medicine compound granule for preventing and treating after cardiac surgery complication | |
| CN106361924A (en) | Pharynx clearing and throat relieving medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |